8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023
Open accessThe DOI matches its Crossref record; 128 of the 129 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and current guidelines recommend the use of GLP-1 receptor agonists in patients with diabetes who need cardiovascular risk reduction, weight management, or both. 38,39”
From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [39]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Weight management programmes have been shown to reduce the progression of type 2 diabetes, improve glycaemia, and reduce the need for glucose-lowering medications. 1”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Research works printed but not linked: 1
- Wing, 2013, Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes, N Engl J Med, 369, 145, 10.1056/NEJMoa1212914 · DOI · Paper page
Cited by
Items 101–200 of 270
Boye, K. S., Sapin, H., Dong, W., WILLIAMSON, S. E., Lee, C. J., & Thieu, V. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01457-7 · Cited by 8
Cerchi, E., Santo, P. A. D. E., de Oliveira, M. C., Janovsky, C. C. P. S., & Halpern, B. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01920-4 · Cited by 9
Fundoiano-Hershcovitz, ., Ritholz, M. D., Horwitz, D. L., Behar, E., Manejwala, O., & Goldstein, P. (2024) · Journal of Medical Internet Research · doi:10.2196/54940 · Cited by 7
Boye, K. S., Poon, J. L., Landó, L. F., Sapin, H., Huh, R., Wang, M., WILLIAMSON, S. E., & Patel, H. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01620-8 · Cited by 8
“Notably, 90% of people with T2D have been classified as living with overweight or obesity [49], and weight reduction is recognised as an important aspect of T2D management [2, 50].”
Assessing Type 2 Diabetes Risk in the Post-Pandemic Era: A Pharmacy-Led FINDRISC Screening Study
Bell, V., Rodrigues, A. R., Costa, V., Dias, C., Alpalhão, M., Martins, I. S., & Forrester, M. (2024) · Life · doi:10.3390/life14121558 · Cited by 7
“Adults with 40 or more years of age and with a body mass index (BMI) over 30 are at greater risk of developing T2D [9–11].”
A roadmap to medical nutrition therapy in type 2 diabetes
Shalit, A., Paschou, S. Α., & Ψαλτοπούλου, Θ. (2023) · HORMONES · doi:10.1007/s42000-023-00483-1 · Cited by 7
“Given the tight association between obesity and T2DM, sustained weight loss is integral to MNT, the aim being for an initial 5–10% loss with greater loss denoting even greater benefit [3].”
BackgroundDifferential Efficacy of Weight Loss Interventions in Patients with Versus Without Diabetes
Losada-Díaz, F., Lizarazo-Bocanegra, S., Perdomo-Lugo, J. J., Gutiérrez-Romero, S. A., Correa-Osio, I., & Mendivil, C. O. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01646-y · Cited by 10
“Bariatric or metabolic surgery must be seriously considered for patients with T2DM and a BMI over 40 kg/m 2 , or with a BMI between 35.0 and 39.9 kg/m 2 who have not responded, or are very unlikely to respond, to non‑surgical methods of obesity treatment [8].”
BackgroundInfluentialLi, S., Li, L., Chen, X., Liu, S., Gao, M., Cheng, X., & Li, C. (2024) · BMC Public Health · doi:10.1186/s12889-024-20317-y · Cited by 8
“This argument highlights the potential emergence of an additional risk factor for DN in the context of rapid or excessive weight loss: fluctuations in body composition, which are often unavoidable during such weight loss [25].”
BackgroundChen, M., Feng, P., Liang, Y., Ye, X., Wang, Y., Liu, Q., Lu, C., Zheng, Q., & Wu, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s485967 · Cited by 9
Pi, L., He, B., Fei, D., Shi, X., & Zhou, Z. (2024) · BMC Primary Care · doi:10.1186/s12875-024-02600-4 · Cited by 6
“Because of the pathophysiological link between T2DM and obesity, weight management is becoming increasingly important [29].”
BackgroundChapagain, D. D., Osei, K. M., Prasiska, D. I., Kimm, H., Rajaguru, V., Kang, S., Kim, T. H., Lee, S. G., & Han, W. M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1514807 · Cited by 6
“The American Heart Association also proposed obesity and weight management as a standard of care for type 2 diabetes in 2023 (47).”
Ren, J., Zhou, L., Li, S., Zhang, Q., & Xiao, X. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00200.2024 · Cited by 9
Ortega, E., Redondo‐Antón, J., Díaz‐Cerezo, S., Santos, M. R., & Romera, I. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03230-7 · Cited by 6
Reducing or Discontinuing Insulin or Sulfonylurea When Initiating a Glucagon-like Peptide-1 Agonist
Herron, E., Cencetti, J., & Matis, J. H. (2024) · Federal Practitioner · doi:10.12788/fp.0452 · Cited by 10
Khee, G. Y., Lim, P. S., Chan, Y. L., & Lee, P. C. (2024) · Pharmacy · doi:10.3390/pharmacy12010031 · Cited by 9
“…treat type 2 diabetes in adults with a body mass index (BMI) ≥ 40 kg/m 2 (37.5 kg/m 2 in Asian individuals) or in adults with a BMI of 35.0–39.9 kg /m 2 (32.5–37.4 kg /m 2 in Asian individuals) who do not achieve durable weight loss and improvements in co-morbidities with nonsurgical methods [18].”
BackgroundInfluentialAgarwal, S. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i3.1457 · Cited by 11
Alawainati, M., Ayoob, Z. A., AlQari, A. A., Makhlooq, F., Naser, H. S., & Bukamal, F. (2023) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_9_23 · Cited by 7
Association between weight loss and HbA1c management in patients with diabetes: a NHANES analysis
Zhang, Z., Gu, P., Li, G., & Du, W. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00440-x · Cited by 6
“The Standards of Care in Diabetes-2023 advocate for weight management programs, highlighting their capacity to mitigate the progression of type 2 diabetes, improve blood glucose levels, and reduce the need for hypoglycemic medications [5].”
The Role of Insulin Resistance in Cardiorenal Metabolic Syndrome
Xiao, J., Song, W. L., Huang, Y., He, X., Weng, Y., & Yu, H. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001048 · Cited by 5
Schumacher, L. M., Bass, S. B., Ard, J. D., Rubin, D. J., Herring, S. J., Rao, A. D., Jones, R. M., & Sarwer, D. B. (2025) · Diabetes Care · doi:10.2337/dci25-0094 · Cited by 6
Strategies to Maintain the Remission of Diabetes Following Metabolic Surgery
Kim, M. K., & Kim, H. S. (2023) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2023.12.2.26 · Cited by 5
“Thus, the Korean guidelines and the ADA/EASD consensus statement suggest that metabolic surgery should be considered as a treatment option for adults with T2DM who are surgical candidates [3,4,7].”
BackgroundVidmar, A. P., Batt, C. E., & Moore, J. M. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.10.008 · Cited by 5
Minari, T. P., Manzano, C. F., Yugar, L. B. T., Sedenho‐Prado, L. G., Rubio, T. D. A., Tácito, L. H. B., Pires, A. C., Vilela-Martin, J. F., Cosenso‐Martin, L. N., Ludovico, N. D., et al. (2024) · Obesities · doi:10.3390/obesities4040033 · Cited by 5
Presence of coronary artery disease in adults with newly detected diabetes mellitus
(2025) · doi:10.1186/s12872-024-04463-0 · Cited by 4
“Screening for other risk factors of macrovascular complications, including hypertension, obesity, and dyslipidemia, is also strongly suggested [4, 7].”
Binge eating disorder: epidemiological, clinical, pathophysiological, and treatment aspects
Starostina, E. G., & Ananyan, M. V. (2024) · Diabetes Mellitus · doi:10.14341/dm13122 · Cited by 5
Pantalone, K. M., Rogen, B., Zirm, P., Xiao, H., Bena, J., Barnard, G., Borukh, E., Peechakara, S., Griebeler, M. L., Young, J. B., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01563-0 · Cited by 4
“The 2023 American Diabetes Association (ADA) Standards of Care emphasize the need to prioritize obesity and weight management for the treatment of type 2 diabetes [7].”
BackgroundMethodInfluentialFilho, A. O. F. M., de Moraes, L. S., de Castilhos, C. B., Santos, L. P., Feóli, A. M. P., Busnello, F. M., Borges, L. R., Marques, A. Y. C., & Abib, R. T. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.06.007 · Cited by 5
Ning, P., Huang, J., Ouyang, H., Feng, Q., Cao, H., Yang, F., & Hou, J. (2025) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2025.04.014 · Cited by 4
Matza, L. S., Stewart, K. D., Redig, J., Howell, T. A., Morris, W., Newson, R. S., Yasui, A., Ishak, J., & Boye, K. S. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2316400 · Cited by 4
Mohamed, T. A., Mckeown, M., & Saxena, M. (2025) · Cureus · doi:10.7759/cureus.78348 · Cited by 7
“This is in accordance with the recommendations of the American Diabetes Association (ADA) [6] and the European Association for the Study of Diabetes (EASD) [5].”
International expert consensus on surgery for type 2 diabetes mellitus
Kermansaravi, M., Omar, I., Finer, N., le Roux, C. W., Carbajo, M. A., Sarwer, D. B., Busetto, L., Ponce, J., Logue, J., Parretti, H. M., et al. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01961-w · Cited by 7
Self-citationSeo, M. H. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.1.5 · Cited by 4
Aberle, J., Lautenbach, A., Meyhöfer, S., Meyhöfer, S. M., Menzen, M., Selig, L., Mai, K., & Blüher, M. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2076-0105 · Cited by 6
Ponirakis, G., Al‐Janahi, I., Elgassim, E., Hussein, R., Petropoulos, I. N., Gad, H., Khan, A., Zaghloul, H. B., Siddique, M. A., Ali, H. A., et al. (2024) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12664 · Cited by 5
“13 A large proportion of glucose lowering medications used for T2D, for example, insulin, sulfonylurea (SU), and thiazolidinedione (TZD), are associated with WG. 14 WG occurs due to increased lipogenesis in muscle and adipose tissues in those on insulin, with defensive snacking to avoid…”
Ebbitt, L. M., Kassel, L. E., McKenzie, J. J., Palm, N. M., & Smith, A. N. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae111 · Cited by 4
Neuropathy of diabetes following initiation of a low-carbohydrate diet: Case report
Sahyouni, M., Acevedo, L. A., Rodriguez, S. C., Chiles, J. A., & Pennings, N. J. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100115 · Cited by 4
Asgari, S., Masrouri, S., Khalili, D., Lotfaliany, M., & Hadaegh, F. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70040 · Cited by 3
Galindo, R. J., Lee, C. J., Allen, S. E., Dib, A., Boye, K. S., Thieu, V. T., Dong, W., Sapin, H., & Wiese, R. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16620 · Cited by 3
“11 There are compelling data documenting an association between increased BMI and other cardiometabolic risk factors (which include type 2 diabetes, hypertension, dyslipidemia, and additional metabolic and cardiovascular risk factors that increase the risk of cardiovascular disease), with shifts…”
Kutoh, E., Kuto, A. N., Okada, R., & Urushibara, N. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04573-2 · Cited by 3
Metabolic-Bariatric Surgery for Type 2 Diabetes: Time(ing) for a Change
Purnell, J. Q. (2024) · Diabetes · doi:10.2337/dbi23-0022 · Cited by 3
Barakat, S., Ramdeen, S., & Khaimova, R. (2024) · Hospital Pharmacy · doi:10.1177/00185787241266803 · Cited by 3
Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review
Belhadj, M., Malek, R., Baghous, H., Boukheloua, M., Arbouche, Z., Nouri, N., Amani, M. E. A., Sersoub, F., & Haireche, M. A. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1495849 · Cited by 4
Hossain, M. U., Rahman, A., Hossain, M. S., Dey, S., Chowdhury, Z. M., Bhattacharjee, A., Ahammad, I., Hasan, M. K., Ahmed, I., Hosen, M. B., et al. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04845-7 · Cited by 3
Kokkinos, P. F., Faselis, C. J., Pittaras, A. E., Samuel, I. B. H., Cadenas‐Sánchez, C., Nylén, E., Lavie, C. J., Franklin, B., Malin, S. K., Murphy, R., et al. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.06.004 · Cited by 5
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes
Zhu, J., & Wilding, J. P. H. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01181-4 · Cited by 4
“%) when newer glucose-lowering medications with body weight reduction effects are included in the treatment regimen [24].”
Saito, M., Usui, I., Sugawara, N., Jojima, T., Sakurai, S., Kishi, H., Sagara, M., Tomaru, T., Iijima, T., Shimoda, K., et al. (2024) · Diabetology International · doi:10.1007/s13340-024-00721-w · Cited by 3
“Therefore, guidelines state that body weight of patients with diabetes should be maintained at an appropriate level [4].”
Asgari, S., Khalili, D., Azizi, F., & Hadaegh, F. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02297-w · Cited by 3
“Notably, the American Diabetes Association (ADA) recommended that 3–7% weight loss is an effective strategy to effectively delay the progression of T2DM in prediabetes people [4].”
BackgroundTiming of gestational diabetes diagnosis and progression to type 2 Diabetes: A comparative analysis
Maor‐Sagie, E., Hallak, M., Haggiag, N., Naeh, A., Toledano, Y., & Gabbay‐Benziv, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111782 · Cited by 3
Trends in Medicare Part D Formulary Coverage for Non-insulin Diabetes Medications, 2020–2024
Buttorff, C., Khodyakov, D., Taylor, E. A., Reid, R. O., Sorbero, M. E. S., & Dworsky, M. S. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09171-1 · Cited by 3
From Calories to Nutrients: The Role of Lifestyle Changes for Addressing Obesity
Shakir, N. (2024) · Tikrit Journal of Pure Science · doi:10.25130/tjps.v29i6.1675 · Cited by 3
Myers, J. W., Park, W. Y., Eddie, A. M., Shinde, A. B., Prasad, P., Murphy, A. C., Leonard, M. Z., Pinette, J. A., Rampy, J., Montufar, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620705 · Cited by 3
“Mice remained on a constant 12-hour light, 12-hour dark cycle throughout the experiment and were housed with 3-5 animals in a cage.”
Duong, A., Heacock, S., Amering, S., Brennan, L., Venci, J. V., & Acquisto, N. M. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231199852 · Cited by 2
Preventing Childhood Obesity in Diabetes: A Critical Imperative
Koohmanaee, S., Pourkazem, S., Rad, A. H., & Nikpour, S. (2024) · Journal of Comprehensive Pediatrics · doi:10.5812/jcp-147829 · Cited by 2
Kushwaha, S., Khanna, P., Bhadada, S. K., Sagar, V., Gupta, P. K., Thakur, J. S., Gupta, M., & Srivastava, R. (2025) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2025.101470 · Cited by 2
Mathematical Modeling in Diabetes Care and Innovation
Maamar, M. H. (2025) · Industrial and applied mathematics · doi:10.1007/978-981-96-1925-2_4 · Cited by 2
Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion
Kushner, P. R., & Dalin, A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01378-5 · Cited by 2
Saito, T., Nojiri, S., Kasai, T., Hiratsuka, Y., Ishijima, M., & Daida, H. (2023) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14591 · Cited by 2
Type 2 Diabetes-Etiology, Epidemiology, Pathogenesis, Treatment
Burns, C., & Francis, N. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_34-3 · Cited by 3
Bayram, F., Sönmez, A., Kiyici, S. K., Akbaş, F., Yetgin, M. K., Yazıcı, D., Çingi, A., Sargın, M., Seniz, U. N. A. L., İŞERİ, C., et al. (2024) · Current Obesity Reports · doi:10.1007/s13679-023-00541-0 · Cited by 3
“Bariatric surgery also may be suggested for patients with poorly controlled type 2 diabetes and class I obesity (BMI between 30 and 35 kg/m 2 ) despite optimal medical management [97].”
Bando, H., Iwatsuki, N., Ogawa, T., & Sakamoto, K. (2023) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2023.10.00247 · Cited by 3
Swift, C., Frazer, M., Gronroos, N. N., Sargent, A., Leszko, M., Buysman, E. K., Alvarez, S., Dunn, T. J., Noone, J. M., & Guevarra, M. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01589-4 · Cited by 2
“…T2DM and overweight/obesity, even a small weight loss can result in improved glycemia and a reduction in cardiovascular risk factors, while a larger weight loss may result in sustained remission of T2DM for at least 2 years and long-term reductions in cardiovascular and mortality risk [11].”
BackgroundPhysical activity in type 2 diabetes mellitus: a review
Burooj, A. (2024) · European Journal of Translational and Clinical Medicine · doi:10.31373/ejtcm/183641 · Cited by 3
“This regimen is to be accompanied by frequent counseling sessions (as many as 16+ sessions in 6 months) to ensure ad - herence and eventual accomplishment of a caloric deficit of more than 500 kcal per day [41].”
BackgroundPharmacotherapy of obesity: State of the art and perspectives
Sićović, K., & Micov, A. M. (2024) · Arhiv za farmaciju · doi:10.5937/arhfarm74-50625 · Cited by 3
Aoyama, K., Nakajima, Y., Meguro, S., & Hayashi, K. (2024) · Diabetology International · doi:10.1007/s13340-024-00744-3 · Cited by 2
“In recent years, obesity has been increasingly recognized as a chronic and progressive disease that significantly increases the risk of type 2 diabetes and is associated with numerous medical, physical, and psychosocial complications [1].”
Changes in diabetes care and management practices during the COVID-19 pandemic
Vashist, K., Frediani, J. K., Weber, M. B., Ali, M. K., Narayan, K. M. V., & Patel, S. A. (2024) · Journal of Public Health · doi:10.1093/pubmed/fdae287 · Cited by 2
Cardoso, C. R. L., Leite, N. C., & Salles, G. F. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110992 · Cited by 2
Obesity, Myokines, and Metabolic Health
Malandrino, N., & Ahima, R. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_56 · Cited by 2
The Impact of Obesity in the UAE: Real-world Physician and Patient Perspectives
Nawar, R., Bhatti, R., Tangı, F., Rai, S., Isailovic, T. V., Khare, S., Artime, E., Higgins, V., Leith, A., & Alawadi, F. (2024) · Dubai Diabetes and Endocrinology Journal · doi:10.18502/ddej.v30i1-2.17931 · Cited by 1
Sriphrapradang, C., Thakkinstian, A., Chinthammit, R., & Nayak, G. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14409 · Cited by 1
“Additionally, in people with T2D living with overweight or obesity, the impact of GLAs on weight must be taken into account 8 .”
Hypertension in People with Diabetic and Chronic Kidney Disease, Obesity, and Renin Secreting Tumors
Khan, S. H., & Weir, M. R. (2025) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-81292-7_3 · Cited by 2
Davis, C., Kleve, S., Huggins, C. E., & Bonham, M. P. (2025) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-025-01750-7 · Cited by 2
“While current guidelines for obesity management recommend a multidisciplinary approach, reducing daily energy intake is a core component [7–10].”
Lotfi, M., Akhondi, M., Ghafari, M., Ghorbi, M. D., Rad, M. N., Marbini, M. S., Ebrahimi, M., Sheikholeslami, S. A., & Azimi, S. A. (2025) · Journal of Parathyroid Disease · doi:10.34172/jpd.2025.13293 · Cited by 1
Current treatment strategies for obesity: pharmacological and non-pharmacological approaches
Reda, A., Sieradocha, K., Śledziewska, A. M., Zagajewska, A., Cyrkler, M., Słupik, D., Giba, A., Krygowska, A. M., & Wasik, M. (2025) · Archiv Euromedica · doi:10.35630/2025/15/4.002 · Cited by 1
Zhao, W., Niu, X., Zhou, X., Shi, R., & Zhou, X. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33885-4.00007-x · Cited by 1
Semaglutide and weight management in the Arab countries: Focus on the United Arab Emirates
Semiz, S. (2025) · Health Sciences Review · doi:10.1016/j.hsr.2025.100244 · Cited by 2
Weight change and diabetes risk following breast cancer: a nationwide cohort study
Jung, W., Jung, J.-H., Cho, I. Y., Yu, J., Baek, J.-H., Han, K., Park, Y., & Shin, D. W. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01898-y · Cited by 1
“The American Diabetes Association recommends a weight loss of at least 5% for managing diabetes [35].”
Luo, C., Zhang, W., Hua, L.-Y., Zeng, M.-Q., Xu, H. J., Duan, C., Xu, S., Zhan, S., Pan, X.-F., Sun, D., et al. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i11.112236 · Cited by 1
Estándares SEA 2026 para el control global del riesgo vascular
Mostaza, J. M., Pintó, X., Armario, P., Guijarro, C., Masana, L., Real, J. T., Arrobas-Velilla, T., Baeza‐Trinidad, R., Calmarza, P., Cebollada, J., et al. (2026) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500889 · Cited by 2
Characterization of jejunal enteroids in human obesity; a model for studying GLP-1 cells
Osinski, C., Martínez-Oca, P., Moret, D., Genser, L., Poitou, C., Soula, H. A., Clément, K., Serradas, P., & Ribeiro, A. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02024-3 · Cited by 1
Educational game on prevention and early diagnosis of type 2 diabetes mellitus for students
da Silva, Á. M. B., Santos, I. T. D. S., Matias, M. E. B., Soares, G. H. D. S., Costa, I. P., Mágero, F. R. L., Padilha, F. M. Q. D. H., & Neto, G. H. F. (2026) · Revista Brasileira de Educação Médica · doi:10.1590/1981-5271v50.1-2025-0041 · Cited by 1
Frailty and overtreatment in older adults with type 2 diabetes in an Argentine health system
Martingano, I., Gutierrez, M. P. L., Macció, A. M., Burgos, M. A., Perman, G., Russo, M. P., & Ratti, M. F. G. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2026.501745 · Cited by 1
Yu, L., Luo, K., He, D., Yu, G., Yu, Y., Yao, H. L., Sun, C., & Wu, X. (2026) · Foods · doi:10.3390/foods15162774 · Cited by 1
“As a major global health challenge, the condition offers only limited therapeutic options, which are primarily restricted to dietary modification, physical activity, pharmacotherapy, and bariatric surgery [4].”
Garvey, W. T., Ard, J. D., Connery, L. E., Frías, J. P., le Roux, C. W., Pietiläinen, K. H., DINESEN, M., Hagen, B. F., Larsen, L., Hesse, D., et al. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00213-5 · Cited by 2
Körperliche Aktivität im Kontext Diabetes mellitus
Joisten, C. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01055-y · Cited by 1
Pathophysiology-Oriented Treatment of Type 2 Diabetes: 10 Case Reports
Nováková, N., Nezval, M., & Molnárová, V. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002857 · Cited by 1
Factors contributing to whether or not people with obesity undergo bariatric surgery
Choi, C.-W., Cunha, D., Helfrich, C. A., & Gill, S. V. (2023) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2023.11.003 · Cited by 1
Ndjaboué, R., Diendere, J. D., Bulver, F., Djossou, A., Ruddy, S., & Ngueta, G. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.11.005 · Cited by 1
Matovinović, M., Belančić, A., Jug, J., Mustač, F., Sirovica, M., Santini, M., Bošnjaković, A., Lovrić, M., & Benčić, M. L. (2024) · Diabetology · doi:10.3390/diabetology5010003 · Cited by 2
“The American Heart Association has advocated for the adoption of preventive measures, emphasizing the importance of addressing obesity in order to alleviate the impact of heart disease [9,10].”
BackgroundMethodMejbel, H. A., Alkhazrajy, L. A., & AbdulRaheem, Y. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03707-4 · Cited by 1
Aberle, J., Lautenbach, A., Meyhöfer, S., Menzen, M., Selig, L., Mai, K., Blüher, M., & Terkamp, C. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0389 · Cited by 1
Rivas, H. P. N., Holst-Schumacher, I. I., Roselló-Araya, M., & Campos-Saborío, N. (2025) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2025.133025 · Cited by 1
Binh, N., Tuấn, N. M., Ngan, N. H., Huy, T. H., Tien, D. P., Hue, L., Giang, D. H., Toan, T. D., & Phuong, P. T. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i7.40 · Cited by 1
Zhang, X.-H., Wu, A.-X., Yang, Z., Sun, K.-W., Yang, T., Wang, N.-S., & Zhang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3256039/v1 · Cited by 1
Sartori, J. (2013) · Sem Aspas · doi:10.29373/sas.v2i1.6927
Identification of Glucagon Secretion Patterns during an Oral Glucose Tolerance Test
Shahidehpour, A., Rashid, M. M., Askari, M. R., Ahmadasas, M., & Çınar, A. (2023) · Endocrines · doi:10.3390/endocrines4030035
Mechanism of metabolic surgery for the treatment of Type 2 Diabetes Mellitus (T2DM)
Leishman, D. J., Ikramuddin, S., & Naitoh, T. (2023) · Mini-invasive Surgery · doi:10.20517/2574-1225.2023.29
Diabetes Prevention on a Research and Clinical Practice Continuum
Delahanty, L. M. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231169690
Lifestyle Medicine Interventions to Manage Hypertension in Brazilian Patients With Type 2 Diabetes
Correia, E. T. D. O. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231197619
Obesity, Myokines, and Metabolic Health
Malandrino, N., & Ahima, R. S. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_56-1
Diabesity Treatments Today and Tomorrow
Pavlakis, G., & Goldman, J. D. (2023) · ADCES in Practice · doi:10.1177/2633559x231202497
Metadata
- Authors
- ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. L., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., Gabbay, R. A., & American Diabetes Association
- ORCID
- ElSayed, Nuha A.
- Aleppo, Grazia
- Aroda, Vanita R.
- Bannuru, Raveendhara R.
- Brown, Florence M.
- Bruemmer, Dennis
- Collins, Billy S.
- Hilliard, Marisa E.
- Isaacs, Diana
- Johnson, Eric L.
- Kahan, Scott
- Khunti, Kamlesh
- Lyons, Sarah K.
- Perry, Mary Lou
- Prahalad, Priya
- Pratley, Richard E.
- Seley, Jane Jeffrie
- Stanton, Robert C.
- Gabbay, Robert A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-12-12
- Volume
- 46
- Issue
- Supplement_1
- Pages
- S128-S139
- ISSN
- 0149-5992 (ISSN-L)
- PMC
- PMC9810466
- OpenAlex
- W4311182596
- Cited by
- 244
- References
- 129
- Citations by year
- 2026: 22 · 2025: 58 · 2024: 95 · 2023: 68
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- obesity, weight management, type 2 diabetes, diabetes prevention, diabetes treatment, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrinology, Humans, Obesity, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.